4//SEC Filing
MESSEMER DEBORAH M. 4
Accession 0001737287-25-000022
CIK 0001737287other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:15 PM ET
Size
5.2 KB
Accession
0001737287-25-000022
Insider Transaction Report
Form 4
MESSEMER DEBORAH M.
Director
Transactions
- Sale
Common Stock
2025-02-18$2.43/sh−13,313$32,351→ 144,316 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/30/2024.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $2.42 to $2.44, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001754424
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 4:15 PM ET
- Size
- 5.2 KB